The Let MI Doctors Decide initiative has released a new report card on the 25 largest health plans within Michigan's Medicare prescription drug program. It examines the use of access restrictions, such as step therapy and prior authorization, on seniors with autoimmune diseases. The new resource is particularly timely given the proposed rule issued by […]

Join us for the first AWIR meeting in Michigan. You do not need to be a member of AWIR to attend and only the first hour is pharma sponsored. DOWNLOAD YOUR COPY

Prior authorization red tape and step therapy delays care and treatment for Michigan patients Michigan physicians, clinicians, and health care providers see it every day. They examine patients, and together form a plan of care, often including additional tests, prescription medicines, and treatments – before insurance companies step in with prior authorization and step therapy red […]

Dear Member: The Michigan Rheumatism Society (MRS) is teaming up with SPARTAN-GRAPPA to present the “SPARTAN-GRAPPA Educational Symposium on Axial Spondyloarthritis (axSpA) and Psoriatric Arthritis (PsA)” on Saturday, October 5, 2019 at the Detroit Marriott Troy, 200 W. Big Beaver in Troy. This CME educational opportunity is geared towards Physicians and Healthcare Professionals. Dress: Business […]

The term spondyloarthritis (SpA) encompasses a spectrum of related inflammatory conditions with a predominance of either axial or peripheral manifestations.1 The figure illustrates the individual diseases within the SpA family spectrum (Figure 1).2 Patients with axial SpA (axSpA) have inflammation in the sacroiliac joints (SIJs) and/or the spine.2 Non-radiographic axSpA (nr-axSpA) comprises a subset of […]